Progress toward therapeutic application of interferons, 1979-1983
- PMID: 6208992
- DOI: 10.1002/1097-0142(19841201)54:2+<2770::aid-cncr2820541425>3.0.co;2-0
Progress toward therapeutic application of interferons, 1979-1983
Abstract
Interferons differ chemically and biologically from other modalities of cancer treatment. They are proteins that inhibit viral replication, influence subcellular processes, slow cellular proliferation, affect cell differentiation, and modulate immune responses. These regulatory effects on cell function undoubtedly underlie the effects of interferons in malignant disease. As a result of efforts by academia, industry, governments, and organizations such as the American Cancer Society, significant progress has been made over the past 5 years in elucidating structure, improving production, and defining clinical applications of interferons for both virus and malignant disease.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous